DLX6 and non-small cell lung carcinoma: Our findings indicate that DLX6-AS1 knockdown activates miR-16, and that activated miR-16 regulates the cell death phenotype seen in NSCLC and cervical cancer cells by Wu et al. [6], and Huang et al. [12], respectively.